Development and in vivo evaluation of mucoadhesive tablets of Rebapimide

Authors

  • Ganesh Kumar Gudas Srikrupa Institute of Pharmaceutical Sciences, Siddipet
  • A. Jaswanth Procadance Institute of Pharmaceutical Sciences, Gajwel
  • V.R.N. Bhikshapathi CMR College of Pharmacy, Kandlakoya, Hyderabad-501401, Telangana

DOI:

https://doi.org/10.7439/ijbar.v7i9.3627

Abstract

The aim of the present work was in vitro and in vivo evaluation of mucoadhesive tablets of rebapimide to prolong the gastric residence time after oral administration. The solubility of rebapimide was enhanced by kneading technique with that mixture formulations were prepared by using 33 full factorial designs to explore the effects of

Downloads

Download data is not yet available.

References

Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm. 1996; 22 (6): 531-539.

Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel. 2000; 63(3): 235

Chavanpatil MD, Jain P, Chaudhari S, Shear R, Vavi PR. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm. 2006; 316(1): 86

Park, K. Robinson, J.R. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharm. 1984; 19(2): 107

Shinde A J. Gastro retentive Drug Delivery System: An Overview. Pharmainfo.net. 2008; 6(1):182.

Hwang S J. Park H. and Park K. Gastric Retentive Drug-Delivery Systems Critical Reviews in Therapeutic Drug Carrier Systems.1998; 15(3):243

Whitehead L. Fell J T and Collett J H. Development of a Gastroretentive Dosage Form. Eur. J. Pharm Sci.1996; 4 (1): 182.

Xiaoling L. and Bhaskara R J. Design of controlled release drug delivery systems. Mc Graw Hill, New York. 2006; 173-176.

Deshpande A. A. Rhodes C T. Shah N H and Malick A W. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev Ind. Pharm.1996; 22 (6): 531-539.

Bardonnet P L. Faivre V. Punj W J. Piffaretti J C.and Falson F. Gastroretentive dosage forms: overview and special case of Helicobact pylori. Journal Control Release. 2006; 111: 1-18.

Bernkop A. Mucoadhesive polymers strategies, achievements and future challenges. Adv Drug Deliv Rev. 2005; 57: 1553-1555.

Thripathi KD, Essentials of Medical Pharmacology, 6th edition: 489-90.

Sweetman SC. Ed Martindale: The complete drug reference. 35th Edition Pharmaceutical Press: London 2007; 1250-1253.

Raymond J, Rowe C, Paul J Sheskey, sian c owen, editors. Handbook of pharmaceutical excipients 5th ed. London: Pharmaceutical Press; 2009: 118-121, 110-114, 185-188, 94-98.

Prasanna Kumari et al., Design and In vivo evaluation of Metoprolol Tartrate bilayer floating tablets in healthy human volunteers. International Journal of Drug Delivery 2014; 6 (1): 14-23.

Bhupesh Dewan, Raghuram Chimata. An open-label, randomized, cross-over bioequivalence study of rebapimide 10 mg under fasting condition, World J Gastrointest Pharmacol Ther 2010; 1(5): 112-118.

Downloads

Published

2016-09-30

Issue

Section

Original Research Articles

How to Cite

Development and in vivo evaluation of mucoadhesive tablets of Rebapimide. (2016). International Journal of Biomedical and Advance Research, 7(9), 460-467. https://doi.org/10.7439/ijbar.v7i9.3627